We are live on ! Find out more
DRTSW icon

Alpha Tau Medical Warrant
DRTSW

21 hedge funds and large institutions have $8.74M invested in Alpha Tau Medical Warrant in 2025 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,746% more capital invested

Capital invested by funds: $473K → $8.74M (+$8.27M)

6.54% more ownership

Funds ownership: 2.93% → 9.47% (+6.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

9% less funds holding

Funds holding: 23 → 21 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
21
Holders Change
-2
Holders Change %
-8.7%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
1
Increased
2
Reduced
2
Closed
3
Calls
$159K
Puts
–
Net Calls
+$159K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
FFM
Fisher Funds Management
New Zealand
+$37.1K
2
UBS Group
UBS Group
Switzerland
+$3.96K
3
WAM
Wolverine Asset Management
Illinois
+$1.65K

Top Sellers

Rank Fund Capital Flow
1
AFG
Allegheny Financial Group
Pennsylvania
-$3.56K
2
VF
Virtu Financial
New York
-$3K
3
Citadel Advisors
Citadel Advisors
Florida
-$1.7K
4
Morgan Stanley
Morgan Stanley
New York
-$605
5
Jane Street
Jane Street
New York
-$71
Name Holding Trade Value Shares
Change 		Change in
Stake
FFM
1
Fisher Funds Management
New Zealand
$8.27M +$37.1K +166,836 New
MI
2
MMCAP International
Cayman Islands
$107K – – –
CPIG
3
Chicago Partners Investment Group
Illinois
$49.6K – – –
MCM
4
Moore Capital Management
New York
$38.5K – – –
VB
5
Value Base
Israel
$36.7K – – –
TCM
6
Tenor Capital Management
New York
$36K – – –
WA
7
Whitebox Advisors
Minnesota
$32.7K – – –
LP
8
LMR Partners
United Kingdom
$27.1K – – –
Jane Street
9
Jane Street
New York
$24.8K -$71 -319 -0.3%
WAM
10
Wolverine Asset Management
Illinois
$23.3K +$1.65K +7,435 +8%
Mariner
11
Mariner
Kansas
$20.7K – – –
CWM
12
Circle Wealth Management
New Jersey
$17.6K – – –
Goldman Sachs
13
Goldman Sachs
New York
$15.3K – – –
CS
14
Clear Street
New York
$15K – – –
RR
15
Robotti Robert
$11K – – –
Citadel Advisors
16
Citadel Advisors
Florida
$7.27K -$1.7K -7,650 -19%
UBS Group
17
UBS Group
Switzerland
$6.25K +$3.96K +17,813 +168%
AT
18
Avalon Trust
New Mexico
$3.19K – – –
EPM
19
Equitec Proprietary Markets
Illinois
$418 – – –
Bank of America
20
Bank of America
North Carolina
$230 – – –
ECM
21
Eisler Capital Management
United Kingdom
$2 – – –
AFG
22
Allegheny Financial Group
Pennsylvania
– -$3.56K -15,000 Closed
VF
23
Virtu Financial
New York
– -$3K -11,349 Closed
Morgan Stanley
24
Morgan Stanley
New York
– -$605 -2,545 Closed

DRTSW Hedge Fund Activity: Q2 2025 in Review

21 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical Warrant (DRTSW) for Q2 2025, worth a combined $8.74M — up 1,746% from $473K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of DRTSW and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Fisher Funds Management, opening a new position worth an estimated $37.1K. The largest seller was Allegheny Financial Group, exiting entirely with an estimated $3.56K sold.

  • 21 institutional investors held Alpha Tau Medical Warrant (DRTSW) as of Q2 2025, down from 23 in Q1 2025.
  • Funds reported $8.74M of Alpha Tau Medical Warrant stock for Q2 2025, up 1,746% quarter-over-quarter.
  • 1 fund opened new Alpha Tau Medical Warrant positions in Q2 2025 and 3 closed out, a net change of -2 holders.
  • The largest Alpha Tau Medical Warrant buyer in Q2 2025 was Fisher Funds Management, an estimated $37.1K added.
  • The largest Alpha Tau Medical Warrant seller in Q2 2025 was Allegheny Financial Group, an estimated $3.56K sold.

Based on aggregated 13F filings for Q2 2025.